SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-125466
Filing Date
2020-11-16
Accepted
2020-11-16 08:50:40
Documents
48
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2029565d1_10q.htm 10-Q 414653
2 EXHIBIT 10.28 tm2029565d1_ex10-28.htm EX-10.28 146753
3 EXHIBIT 31.1 tm2029565d1_ex31-1.htm EX-31.1 8358
4 EXHIBIT 32.1 tm2029565d1_ex32-1.htm EX-32.1 3640
  Complete submission text file 0001104659-20-125466.txt   3780924

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ttnp-20200930.xml EX-101.INS 933370
6 XBRL TAXONOMY EXTENSION SCHEMA ttnp-20200930.xsd EX-101.SCH 28438
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ttnp-20200930_cal.xml EX-101.CAL 34832
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ttnp-20200930_def.xml EX-101.DEF 103555
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttnp-20200930_lab.xml EX-101.LAB 258915
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttnp-20200930_pre.xml EX-101.PRE 216765
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-13341 | Film No.: 201313928
SIC: 2836 Biological Products, (No Diagnostic Substances)